NTRB סך נכסי הפעילות העסקית Nutriband Corp

Nutriband Inc. (NTRB) is developing innovative transdermal systems with overdose protection, minimizing patent threats by applying the technology across various types of analgesics. This price action reflects that total assets amount to 8.23. The business relies on the success of medical trials and remains independent of economic cycles, although market capitalization and access to investment depend on macroeconomics.

This metric is a reverse derivative of return on assets (ROA), combining equity and liabilities to restore continuous resource dynamics between reporting periods. Analyzing the total asset level of Nutriband Inc. allows for an assessment of the scaling of its material base, where the growth in asset value directly reflects investments in the development of the proprietary Aversa technology for transdermal systems.